The research team will capitalize on the breadth and depth of these data to explore and quantify predictors of insulin progression and to identify potential opportunities for health behavior intervention in order to improve T2DM treatment and clinical outcomes. This evidence concerns the gene INS and type 2 diabetes mellitus.